Litigation Resource Community

Title	Views
1	Introducing LexisNexis Author Steve Posner’s Blog On Privacy, Surveillance Issues	7374
2	Mealey's Litigation Report: Discovery	6183
3	Welcome To Our New Communities!	5897

Title

Views

Introducing LexisNexis Author Steve Posner’s Blog On Privacy, Surveillance Issues

7374

Mealey's Litigation Report: Discovery

6183

Welcome To Our New Communities!

5897

Title	Downl.
1	Mealey's Litigation Report: Discovery	43
2	Mealey’s Litigation Report: Class Actions	8
3	5th New York Courts Newsletter Covers Hot Topics, Trends	8

Title

Downl.

Mealey's Litigation Report: Discovery

Mealey’s Litigation Report: Class Actions

5th New York Courts Newsletter Covers Hot Topics, Trends

N.J. Risperdal Jury Finds Diabetes Warning Lacking, But Drug Didn't Cause Disease

NEW BRUNSWICK, N.J. - (Mealey's) A Risperdal personal injury trial ended Feb. 16 in a defense verdict for Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. after a New Jersey state court jury found that Janssen failed to warn about the...

Published Fri, Feb 17 2012 1:44 PM by Tom Moylan

Filed under: litigation, Seroquel, verdict, personal injury, diabetes, antipsychotic drug, Risperdal, drugs, Zyprexa, AstraZeneca, et al., New Jersey, mass tort, amp, Johnson, Johnson &amp, Eli Lilly and Co., Janssen Pharmaceuticals, Gary D. Skala, Gary D. Skala v. Johnson &amp
AstraZeneca Pays States $68.5M For Off-Label Marketing Of Seroquel Antipsychotic

TRENTON, N.J. - (Mealey's) AstraZeneca Pharmaceuticals L.P. and AstraZeneca L.P. on March 10 agreed to pay $68.5 million to 37 states and the District of Columbia to resolve allegations in a New Jersey state court lawsuit that it marketed its atypical...

Published Fri, Mar 11 2011 12:07 PM by Tom Moylan

Filed under: litigation, Seroquel, antipsychotic drug, Risperdal, Zyprexa, AstraZeneca, Dow v. AstraZeneca, off-label use, New Jersey Attorney General
AstraZeneca Agrees To Settle 17,500 Seroquel Cases For $198 Million

WILMINGTON, Del. — AstraZeneca announced Aug. 9 that it has reached agreements in principle to settle about 17,500 Seroquel claims in the United States for about $198 million. “The specific terms of the agreements, which are the result of...

Published Mon, Aug 9 2010 3:28 PM by Tom Moylan

Filed under: lawsuit, litigation, Seroquel, settlement, drugs, AstraZeneca
AstraZeneca Settles Nearly 4,000 Seroquel Injury Claims; Terms Confidential

LONDON - (Mealey's) AstraZeneca PLC said July 29 that it has agreed in principle to settle with nearly 4,000 Seroquel product liability plaintiffs. The company said settlement terms are confidential. In notes to its second-quarter financial report...

Published Fri, Jul 30 2010 10:40 AM by Tom Moylan

Filed under: litigation, Seroquel, torts, personal injury, multidistrict litigation, Janssen, drugs, product liability, Eli Lilly, settle, AstraZeneca, Bristol-Myers Squibb

Litigation Resource Community

Featured Content

You are not logged in. Please Login to add content to your community page

Visit Other Communities By

Latest Postings

Most Viewed Postings

Popular Downloads

N.J. Risperdal Jury Finds Diabetes Warning Lacking, But Drug Didn't Cause Disease

AstraZeneca Pays States $68.5M For Off-Label Marketing Of Seroquel Antipsychotic

AstraZeneca Agrees To Settle 17,500 Seroquel Cases For $198 Million

AstraZeneca Settles Nearly 4,000 Seroquel Injury Claims; Terms Confidential